Compare T-Mobile Us Inc (TMUS) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
T-Mobile Us Inc vs Twist Bioscience Corp — how do they compare? T-Mobile Us Inc trades at $190.56 (market cap $211.72B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: T-Mobile Us Inc is far larger — about 38.8× Twist Bioscience Corp's market cap, and T-Mobile Us Inc pays a 2.09% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| TMUS | TWST | |
|---|---|---|
Market Cap | $211.72B | $5.45B |
Sector | Media | Health |
52-Week High | $259.01 | $102.88 |
52-Week Low | $167.65 | $24.16 |
Enterprise Value | $329.42B | $5.37B |
Dividend Yield | 2.09% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About T-Mobile Us Inc
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, creating T-Mobile Us. Following the merger, the firm provided nationwide service in major markets but spottier coverage elsewhere. T-Mobile spent aggressively on low-frequency spectrum, well suited to broad coverage, and has substantially expanded its geographic footprint. This expansion, coupled with aggressive marketing and innovative offerings, produced rapid customer growth. With the Sprint acquisition, the firm's scale now roughly matches its larger rivals: T-Mobile now serves 71 million postpaid and 21 million prepaid phone customers, equal to around 30% of the U.S. retail wireless market. In addition, the firm provides wholesale service to resellers.
Read more on TMUS →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
